BRPI0914971A2 - composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas - Google Patents

composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas

Info

Publication number
BRPI0914971A2
BRPI0914971A2 BRPI0914971A BRPI0914971A BRPI0914971A2 BR PI0914971 A2 BRPI0914971 A2 BR PI0914971A2 BR PI0914971 A BRPI0914971 A BR PI0914971A BR PI0914971 A BRPI0914971 A BR PI0914971A BR PI0914971 A2 BRPI0914971 A2 BR PI0914971A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
compositions containing
antibiotic drug
fluoroquinolone antibiotic
containing fluoroquinolone
Prior art date
Application number
BRPI0914971A
Other languages
English (en)
Inventor
Martinez Carmen
Javier Calán Francisco
Campins Inmaculada
Carreras Nuria
Jimenez Nuria
Vidal Roman
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40857591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0914971(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BRPI0914971A2 publication Critical patent/BRPI0914971A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0914971A 2008-06-09 2009-05-29 composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas BRPI0914971A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5987708P 2008-06-09 2008-06-09
PCT/US2009/045549 WO2009151974A1 (en) 2008-06-09 2009-05-29 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug

Publications (1)

Publication Number Publication Date
BRPI0914971A2 true BRPI0914971A2 (pt) 2017-06-20

Family

ID=40857591

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914971A BRPI0914971A2 (pt) 2008-06-09 2009-05-29 composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas

Country Status (16)

Country Link
US (2) US8450311B2 (pt)
EP (1) EP2299974A1 (pt)
JP (1) JP5509201B2 (pt)
KR (1) KR101587056B1 (pt)
CN (3) CN102056590A (pt)
AR (1) AR072071A1 (pt)
AU (1) AU2009257778B2 (pt)
BR (1) BRPI0914971A2 (pt)
CA (1) CA2726616A1 (pt)
CL (1) CL2009001379A1 (pt)
MX (1) MX2010012933A (pt)
RU (1) RU2494727C2 (pt)
TW (2) TWI544934B (pt)
UY (1) UY31880A (pt)
WO (1) WO2009151974A1 (pt)
ZA (1) ZA201008543B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
CN103181892A (zh) * 2013-02-20 2013-07-03 南京恒道医药科技有限公司 盐酸莫西沙星滴眼液及其制备方法
CN105687127B (zh) * 2016-01-29 2018-09-28 上海利康瑞生物工程有限公司 关节腔用盐酸莫西沙星几丁糖注射液及其制备方法
CN110354074A (zh) * 2019-08-16 2019-10-22 合肥华威药业有限公司 一种缓释型盐酸莫西沙星眼用制剂及其制备方法
CN113797163B (zh) * 2020-06-17 2023-07-14 成都瑞沐生物医药科技有限公司 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂
US11298315B2 (en) 2020-08-26 2022-04-12 Somerset Therapeutics, Llc. Triamcinolone and moxifloxacin compositions
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
ATE300936T1 (de) * 1992-05-06 2005-08-15 Alcon Lab Inc Anwendung von boral-polyol-komplexen für ophthalmische arzneizusammensetzungen
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
ATE326983T1 (de) 1996-12-13 2006-06-15 Alcon Lab Inc Aminoalkohole enthaltende ophthalmische zusammensetzungen
RU2130189C1 (ru) 1997-02-20 1999-05-10 Александр Сергеевич Парфенов Способ определения тканевого холестерина кожи
NZ506921A (en) 1998-04-07 2002-02-01 Alcon Lab Inc Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
ATE243038T1 (de) 1999-11-01 2003-07-15 Alcon Inc Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend
US20010049366A1 (en) 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
DK1305033T3 (da) 2000-07-28 2005-01-31 Alcon Inc Farmaceutiske pæaparater indeholdende tobramycin og xanthangummi
AU2002226926A1 (en) 2000-12-20 2002-07-01 Alcon, Inc. Antifungal compositions containing an antibiotic and one or more amidoamines
US20060141059A1 (en) 2004-12-27 2006-06-29 Alcon, Inc. Self-preserved ophthalmic pharmaceutical compositions containing tobramycin
BRPI0719776A2 (pt) 2006-10-12 2014-04-22 Kyorin Seiyaku Kk Preparação líquida aquosa tendo penetração de gatifloxacino intraocular melhorada
BRPI0719514A2 (pt) * 2006-10-12 2014-10-07 Kyorin Seiyaku Kk Preparações líquidas aquosas compreendendo gatifloxacina
US7795316B1 (en) 2007-12-19 2010-09-14 Alcon Research, Ltd. Topical ophthalmic compositions containing tobramycin and dexamethasone
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
WO2010004594A1 (en) 2008-07-08 2010-01-14 S.I.F.I. Societa' Industria Farmaceutica Italiana S.P.A. Ophthalmic compositions for treating pathologies of the posterior segment of the eye

Also Published As

Publication number Publication date
US20090306128A1 (en) 2009-12-10
TWI495469B (zh) 2015-08-11
CN103550141A (zh) 2014-02-05
JP5509201B2 (ja) 2014-06-04
MX2010012933A (es) 2011-01-25
RU2494727C2 (ru) 2013-10-10
CL2009001379A1 (es) 2010-09-10
TWI544934B (zh) 2016-08-11
AR072071A1 (es) 2010-08-04
KR20110039219A (ko) 2011-04-15
ZA201008543B (en) 2012-02-29
TW201000102A (en) 2010-01-01
EP2299974A1 (en) 2011-03-30
CA2726616A1 (en) 2009-12-17
AU2009257778A1 (en) 2009-12-17
US9114168B2 (en) 2015-08-25
RU2010154545A (ru) 2012-07-20
JP2011522823A (ja) 2011-08-04
CN102056590A (zh) 2011-05-11
AU2009257778B2 (en) 2014-09-11
WO2009151974A1 (en) 2009-12-17
TW201503909A (zh) 2015-02-01
UY31880A (es) 2009-11-10
KR101587056B1 (ko) 2016-01-21
US8450311B2 (en) 2013-05-28
US20130137715A1 (en) 2013-05-30
CN104814961A (zh) 2015-08-05

Similar Documents

Publication Publication Date Title
LTPA2018005I1 (lt) Farmacinė kompozicija
SMT201600259B (it) Composizioni farmaceutiche antibatteriche
BR112012003592A2 (pt) composição farmacêutica contendo derivado de quinolina
BRPI0914971A2 (pt) composições farmacêuticas que contêm fármaco antibiótico de fluoroquinolonas
BRPI0721651A2 (pt) Composição farmacêutica
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0715712A2 (pt) Composição farmacêutica
DK2692341T3 (da) Misbrugs-resistent lægemiddelformulering
BRPI0719393A2 (pt) Composição farmacêutica
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
DK2120884T3 (da) Farmaceutisk sammensætning
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI0720234A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2285413T3 (da) Farmaceutisk sammensætning
BRPI0921654A2 (pt) formulação farmacêutica
AP3542A (en) Anti-malarial pharmaceutical composition
BRPI0921313A2 (pt) composição farmaucêutica
EP2465512A4 (en) PAIN-SUBJECTIVE PHARMACEUTICAL COMPOSITION
BRPI0912171A2 (pt) composição farmacêutica
BRPI0806938A2 (pt) Composição farmacêutica contedo um derivado de camptotecina
EP2306998A4 (en) PHARMACEUTICAL FORMULATION
EP2116241A4 (en) PHARMACEUTICAL COMPOSITION
BRPI0921301A2 (pt) composição farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]